← Research library

GHRP-6

Growth hormone axis · By Preptide Pro editorial team · Last updated

GHRP-6 is a growth hormone axis peptide, and it is not FDA-approved. One of the first synthetic growth hormone-releasing hexapeptides. It is used mainly in research on the ghrelin receptor.

Not FDA-approved

Chemistry (PubChem)

PubChem CID4345065
CAS numberNot listed
Molecular formulaC46H56N12O6
Molecular weight873 g/mol
Other namesGhrp-6, RefChem:201055, GHRP-2 Acetate, h-his-d-trp-ala-trp-d-phe-lys-nh2, orb341840, GTPL1093, PGH-3694-PI, C46H56N12O6

Is GHRP-6 FDA-approved?

Not FDA-approved. No matching NDA or BLA was found in openFDA (Drugs@FDA).

How much research is there on GHRP-6?

PubMed lists 788 records for “GHRP-6”, of which 50 are tagged as human clinical trials.

Most recent PubMed records
Recent studyJournalDate
Phase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.J Clin Neurosci2026 Oct
Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.Sex Med Rev2026 Sep 30
Ghrelin Receptor Blockade Restricts Hepatic Echinococcus granulosus Infection by Suppressing Host Cell Proliferation and Enhancing Fibrotic Encapsulation.Acta Parasitol2026 Sep 26
Ghrelin attenuates hypoxia-induced mitochondrial oxidative stress damage in HTR-8/SVneo trophoblasts.Tissue Cell2026 Sep 10
A discovery-based proteomic approach of epidermal growth factor and growth hormone-releasing peptide-6 in a model of acute ischemic stroke.Pharmacol Rep2026 Aug

Sources

This is general research information, not medical advice. Check with a clinician before using any compound.

Preptide Pro is a tracking tool, not medical advice. Talk to a clinician about any treatment.